Department of Radiation Oncology


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Differences in Dose Coverage and Uniformity in Fractionated High-Dose-Rate Interstitial Breast Brachytherapy Based on EMT Measurements (2016) Kellermeier M, Hofmann B, Strnad V, Bert C Conference contribution Response to 6 cycles of chemotherapy with FOLFIRINOX is predictive of overall survival in patients with locally advanced unresectable pancreatic cancer (2016) Haderlein M, Lubgan D, Lettmaier S, Semrau S, Wolf W, Golcher H, Hohenberger W, Fietkau R Conference contribution Effective long-term local results and prognostic factors after fractionated stereotactic radiotherapy of 257 intracranial meningeoma (2016) Lubgan D, Rutzner S, Semrau S, Lambrecht U, Roessler K, Buchfelder M, Fietkau R Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial) (2016) Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, et al. Conference contribution Tumor infiltrating cells - cell-to-cell distances enable differentiation between functionally active and suppressed inflammatory cells (2016) Distel L, Nagl S, Fietkau R, Haas M Conference contribution The Treatment Reality of Octogenarians with Bladder Cancer in a Maximum Care Hospital (2016) Sikic D, Wach S, Taubert H, Richterstetter M, Kunath F, Lieb V, Krause S, et al. Conference contribution Temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine (2016) Stritzelberger J, Distel T, Fietkau R, Putz F Conference contribution THE IMPACT OF LOW-DOSE RADIATION ON INFLAMMATORY DISEASES (2016) Deloch L, Derer A, Hueber A, Fietkau R, Frey B, Gaipl U Conference contribution Oxidized silicon nanoparticles and iron oxide nanoparticles for radiation therapy (2016) Klein S, Kizaloglu M, Dell'Acriprete ML, Neuhuber W, Distel L, Gonzales MC, Kryschi C Conference contribution